Columnist Joe MacDonald recalls how he ended up including extended family in his immediate family's Thanksgiving celebration in the hospital.

Hemophilia patients who received intensive factor VIII (FVIII) replacement therapy for better joint health were nearly five ...

Pfizer’s Hympavzi (marstacimab) has been approved in the European Union (EU) to prevent or reduce the frequency of bleeding episodes in adults and children, ages 12 and older, with severe hemophilia A ...

The Coalition for Hemophilia B held its annual women’s retreat Nov. 14-17 in Alpharetta, Georgia. Initially scheduled for September, the event was postponed due to Hurricane Helene. Despite the delay, ...